RAD-140 Completed Phase 1 Trials for Hormone Receptor Positive Malignant Neoplasm of Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03088527
Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Breast Cancer